News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mirna Therapeutics, Inc. and Horizon Discovery Ltd. Publication Elucidates Novel miR-34 Tumor Suppressor Pathway, Underscores miR-34 as Important Anticancer Approach


6/26/2013 9:45:57 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AUSTIN, Texas & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Mirna Therapeutics, Inc. and Horizon Discovery Ltd. announced today the publication of new data providing further confirmation that microRNA-34 (miR-34), and the tumor suppressor pathways it controls, is an important potential target for a wide variety of cancers. The data are published in Molecular Therapy, the official journal of the American Society of Gene and Cell Therapy, and reveals a novel mechanism through which miR-34 exerts its tumor suppressor function in cancers.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES